Logo image of ROGS.OL

ROGALAND SPAREBANK (ROGS.OL) Stock Fundamental Analysis

OSL:ROGS - Euronext Oslo - NO0006001007 - Common Stock - Currency: NOK

138.98  +1.38 (+1%)

Fundamental Rating

3

ROGS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 92 industry peers in the Banks industry. ROGS may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ROGS is valued expensive at the moment. ROGS also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ROGS had positive earnings in the past year.
ROGS had a negative operating cash flow in the past year.
In the past 5 years ROGS has always been profitable.
ROGS had negative operating cash flow in 4 of the past 5 years.
ROGS.OL Yearly Net Income VS EBIT VS OCF VS FCFROGS.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

The Return On Assets of ROGS (0.73%) is comparable to the rest of the industry.
ROGS has a Return On Equity of 6.74%. This is in the lower half of the industry: ROGS underperforms 67.39% of its industry peers.
Industry RankSector Rank
ROA 0.73%
ROE 6.74%
ROIC N/A
ROA(3y)0.62%
ROA(5y)0.6%
ROE(3y)5.82%
ROE(5y)5.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROGS.OL Yearly ROA, ROE, ROICROGS.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6

1.3 Margins

The Profit Margin of ROGS (24.23%) is better than 64.13% of its industry peers.
In the last couple of years the Profit Margin of ROGS has remained more or less at the same level.
The Operating Margin and Gross Margin are not available for ROGS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 24.23%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y0.14%
PM growth 5Y0.01%
GM growth 3YN/A
GM growth 5YN/A
ROGS.OL Yearly Profit, Operating, Gross MarginsROGS.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1

2. Health

2.1 Basic Checks

ROGS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ROGS has been increased compared to 1 year ago.
The number of shares outstanding for ROGS remains at a similar level compared to 5 years ago.
Compared to 1 year ago, ROGS has an improved debt to assets ratio.
ROGS.OL Yearly Shares OutstandingROGS.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ROGS.OL Yearly Total Debt VS Total AssetsROGS.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

ROGS has a Debt/Equity ratio of 4.14. This is a high value indicating a heavy dependency on external financing.
ROGS has a Debt to Equity ratio of 4.14. This is amonst the worse of the industry: ROGS underperforms 82.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.14
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC5.96%
ROGS.OL Yearly LT Debt VS Equity VS FCFROGS.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ROGS.OL Yearly Current Assets VS Current LiabilitesROGS.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 30.56% over the past year.
ROGS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.81% yearly.
Looking at the last year, ROGS shows a very strong growth in Revenue. The Revenue has grown by 25.25%.
Measured over the past years, ROGS shows a quite strong growth in Revenue. The Revenue has been growing by 9.48% on average per year.
EPS 1Y (TTM)30.56%
EPS 3Y15.8%
EPS 5Y10.81%
EPS Q2Q%32.14%
Revenue 1Y (TTM)25.25%
Revenue growth 3Y16.73%
Revenue growth 5Y9.48%
Sales Q2Q%22.77%

3.2 Future

Based on estimates for the next years, ROGS will show a decrease in Earnings Per Share. The EPS will decrease by -2.27% on average per year.
The Revenue is expected to grow by 2.29% on average over the next years.
EPS Next Y-6.75%
EPS Next 2Y-5.3%
EPS Next 3Y-2.27%
EPS Next 5YN/A
Revenue Next Year3.53%
Revenue Next 2Y2.36%
Revenue Next 3Y2.29%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ROGS.OL Yearly Revenue VS EstimatesROGS.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ROGS.OL Yearly EPS VS EstimatesROGS.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 9.86, which indicates a very decent valuation of ROGS.
60.87% of the companies in the same industry are cheaper than ROGS, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.20. ROGS is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 11.74 indicates a reasonable valuation of ROGS.
70.65% of the companies in the same industry are cheaper than ROGS, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.13, ROGS is valued a bit cheaper.
Industry RankSector Rank
PE 9.86
Fwd PE 11.74
ROGS.OL Price Earnings VS Forward Price EarningsROGS.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ROGS.OL Per share dataROGS.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

A cheap valuation may be justified as ROGS's earnings are expected to decrease with -2.27% in the coming years.
PEG (NY)N/A
PEG (5Y)0.91
EPS Next 2Y-5.3%
EPS Next 3Y-2.27%

7

5. Dividend

5.1 Amount

ROGS has a Yearly Dividend Yield of 7.06%, which is a nice return.
ROGS's Dividend Yield is rather good when compared to the industry average which is at 5.03. ROGS pays more dividend than 85.87% of the companies in the same industry.
ROGS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 7.06%

5.2 History

The dividend of ROGS is nicely growing with an annual growth rate of 16.30%!
Dividend Growth(5Y)16.3%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

84.72% of the earnings are spent on dividend by ROGS. This is not a sustainable payout ratio.
ROGS's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP84.72%
EPS Next 2Y-5.3%
EPS Next 3Y-2.27%
ROGS.OL Yearly Income VS Free CF VS DividendROGS.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B
ROGS.OL Dividend Payout.ROGS.OL Dividend Payout, showing the Payout Ratio.ROGS.OL Dividend Payout.PayoutRetained Earnings

ROGALAND SPAREBANK

OSL:ROGS (5/28/2025, 7:00:00 PM)

138.98

+1.38 (+1%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-13 2025-08-13
Inst Owners30.64%
Inst Owner ChangeN/A
Ins Owners6.82%
Ins Owner ChangeN/A
Market Cap3.48B
Analysts80
Price Target145.52 (4.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.06%
Yearly Dividend11.09
Dividend Growth(5Y)16.3%
DP84.72%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.96%
Min EPS beat(2)8.29%
Max EPS beat(2)63.64%
EPS beat(4)3
Avg EPS beat(4)18.46%
Min EPS beat(4)-2.31%
Max EPS beat(4)63.64%
EPS beat(8)4
Avg EPS beat(8)12.88%
EPS beat(12)6
Avg EPS beat(12)7.16%
EPS beat(16)9
Avg EPS beat(16)10.67%
Revenue beat(2)1
Avg Revenue beat(2)8.11%
Min Revenue beat(2)-6.12%
Max Revenue beat(2)22.35%
Revenue beat(4)2
Avg Revenue beat(4)4.29%
Min Revenue beat(4)-6.12%
Max Revenue beat(4)22.35%
Revenue beat(8)4
Avg Revenue beat(8)5.19%
Revenue beat(12)6
Avg Revenue beat(12)5.28%
Revenue beat(16)10
Avg Revenue beat(16)4.56%
PT rev (1m)0%
PT rev (3m)0.71%
EPS NQ rev (1m)-13.02%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.34%
Revenue NQ rev (1m)0.34%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.63%
Revenue NY rev (3m)0.3%
Valuation
Industry RankSector Rank
PE 9.86
Fwd PE 11.74
P/S 2.93
P/FCF N/A
P/OCF N/A
P/B 0.81
P/tB 0.81
EV/EBITDA N/A
EPS(TTM)14.1
EY10.15%
EPS(NY)11.84
Fwd EY8.52%
FCF(TTM)-20.24
FCFYN/A
OCF(TTM)-20.22
OCFYN/A
SpS47.48
BVpS170.8
TBVpS170.58
PEG (NY)N/A
PEG (5Y)0.91
Profitability
Industry RankSector Rank
ROA 0.73%
ROE 6.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 24.23%
GM N/A
FCFM N/A
ROA(3y)0.62%
ROA(5y)0.6%
ROE(3y)5.82%
ROE(5y)5.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y0.14%
PM growth 5Y0.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 4.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC5.96%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.56%
EPS 3Y15.8%
EPS 5Y10.81%
EPS Q2Q%32.14%
EPS Next Y-6.75%
EPS Next 2Y-5.3%
EPS Next 3Y-2.27%
EPS Next 5YN/A
Revenue 1Y (TTM)25.25%
Revenue growth 3Y16.73%
Revenue growth 5Y9.48%
Sales Q2Q%22.77%
Revenue Next Year3.53%
Revenue Next 2Y2.36%
Revenue Next 3Y2.29%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-262.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-264.03%
OCF growth 3YN/A
OCF growth 5YN/A